X4 Pharmaceuticals
Price & Volume
Stats
See moreOpen | $0.44 |
Previous Close | $0.45 |
Day Range | $0.42-$0.45 |
52W Range | $0.26-$1.60 |
Market Cap | $77.3M |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $1.1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $628,000 |
Diluted EPS | -$0.08 |
News
See moreYahoo Finance • 6 days ago
X4 Pharmaceuticals and taiba rare Announce Exclusive Agreement for the Distribution and Commercialization of XOLREMDI® (mavorixafor) in WHIM Syndrome in Select Middle East Countries
Yahoo Finance • 19 days ago
X4 Pharmaceuticals Announces Strategic Restructuring to Drive Value and Maximize Opportunity for Mavorixafor in Chronic Neutropenia
Yahoo Finance • 22 days ago
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Paula Ragan Ph.D. |
Address | 61 North Beacon Street, Boston, MA, United States, 02134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 143 |
